For developing high-performance pure organic light-emitting diode (OLED) emitters, thermally activated delayed fluorescence (TADF) and hybrid local and charge-transfer (HLCT) mechanisms are two pivotal strategies by harvesting triplet excitons via reverse intersystem crossing. The intrinsic relationship between the two in molecular design is revealed in this study: the switching between TADF and HLCT mechanisms can be achieved by adjusting the strength of the donor groups. In this work, five D-π-A-π-D type blue and green OLED emitters with acridine/phenoxazine/phenothiazine groups as donors were designed and synthesized. Compared to reported HLCT molecules adopting carbazole/diphenylamine groups as donors, the excited states of the molecules in this work were successfully regulated to TADF. The solution-processed blue/green OLED device based on FIP-DPAC/FIP-PXZ achieved the maximum external quantum efficiency (EQEmax) of 10.01%/17.45%. A strategy for regulating HLCT and TADF mechanisms of OLED emitters through donor molecular engineering was elucidated in this study.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: